New Paper Makes the Case for AI-Specific Guidance in Research Oversight
AI is becoming a routine part of how research proposals are prepared and reviewed, from drafting applications to supporting administrative
Institutional Biosafety Committee (IBC)
The Executive Order that Brings Private Bioresearch Under Federal Oversight
The release of ICH E6(R3) in January 2025 marks the most significant evolution in Good Clinical Practice (GCP) guidelines in over a decade. More than a revision, E6(R3) marks a shift from traditional practices—making participant safety and data reliability not just priorities, but design drivers, and introducing risk-based proportionality as a foundational approach.